Anorectal Malformations: Ideal Surgery Timing to Reduce Incontinence and Optimize QoL.
Gloria PelizzoCarlotta Paola Maria CanonicaFrancesca DestroMilena MeroniDario RizzoLorena CanazzaGiorgio Giuseppe Orlando SelvaggioEleonora DuranteGian Vincenzo ZuccottiValeria CalcaterraPublished in: Children (Basel, Switzerland) (2023)
Anorectal malformations (ARMs) are rare and involve a wide spectrum of malformations. Prenatal diagnosis is often incomplete, and the diagnostic pathway is started during the newborn period to identify the type of malformation and the correct treatment. This retrospective study included patients between 8 and 18 y.o. diagnosed with ARM, referring to Our Clinic. We proposed two questionnaires, Rintala Bowel Function Score and the Fecal Incontinence Quality of Life Scale, and we defined four groups referring to surgical timing (age in months < 3, 3-6, 6-9, >9). In total, 74 patients were recruited (mean age 13.05 ± 2.80 y.o.), and data analysis showed a significant relationship between comorbidity and surgical timing. Moreover, timing was related to outcome in terms of fecal continence (better if surgery performed before 3 months) and Quality of Life (QoL). QoL, however, is influenced by other factors (emotional and social life, psychological sphere and take of care of chronic disease). We considered rehabilitation programs, more often practiced by children who underwent surgery after 9 months, to maintain an appropriate relational life. This study highlights the importance of surgical timing as the first step of a multidisciplinary follow-up, taking care of the child in every phase of his growth, tailored to the single patient.
Keyphrases
- minimally invasive
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- data analysis
- coronary artery bypass
- chronic kidney disease
- prognostic factors
- mental health
- palliative care
- quality improvement
- public health
- young adults
- coronary artery disease
- surgical site infection
- urinary incontinence
- health insurance
- patient reported
- affordable care act
- replacement therapy